Literature DB >> 12867398

Long-term graft survival after penetrating keratoplasty.

Robert W Thompson1, Marianne O Price, Patrick J Bowers, Francis W Price.   

Abstract

PURPOSE: To determine long-term graft survival rates and causes of secondary graft failures for a large series of penetrating keratoplasties (PKPs).
DESIGN: Retrospective, noncomparative case series. PARTICIPANTS: Longitudinal review of 3992 consecutive eyes that underwent PKP at a large tertiary care referral center from 1982 through 1996. Data were collected retrospectively from August 1982 through December 1988 and prospectively thereafter. INTERVENTION: Three thousand six hundred forty primary grafts and 352 regrafts. MAIN OUTCOME MEASURES: Corneal graft survival and etiology of graft failures. Patients were evaluated preoperatively and at 1, 3, 6, 9, 12, 18, and 24 months after transplant, then at yearly intervals.
RESULTS: Mean recipient age was 67 years (range, 1-98 years). The predominant indications for PKP were pseudophakic bullous keratopathy (32%) and Fuchs' dystrophy (23%). Graft failure occurred in 10% (385) of the eyes. The most common causes of secondary graft failure were endothelial failure (29%) or immunologic endothelial rejection (27%). Survival of first time grafts was 90% at 5 years and 82% at 10 years. Initial regrafts had significantly lower 5-year and 10-year survival rates, 53% and 41%, respectively. The highest 5-year and 10-year survival rates were noted in primary grafts for eyes with a preoperative diagnosis of keratoconus (97% and 92%, respectively), or Fuchs' dystrophy (97% and 90%, respectively). Primary grafts for aphakic bullous keratopathy without intraocular lens placement had the lowest 5-year survival rate, 70%.
CONCLUSIONS: The 5-year and 10-year survival rates in this series demonstrate that PKP is a safe and effective treatment for the corneal diseases commonly transplanted in the United States. However, endothelial failure and immunologic graft rejection were persistent risks over the long term, supporting the need for continued patient follow-up. Regrafts, aphakic eyes without intraocular lens placement at the time of transplant, and corneas with deep stromal vascularization had reduced graft survival rates. Pseudophakic bullous keratopathy grafts with a retained posterior chamber intraocular lens were at increased risk of endothelial failure compared with primary grafts done for other causes or compared with pseudophakic bullous keratopathy grafts done with intraocular lens exchange.

Entities:  

Mesh:

Year:  2003        PMID: 12867398     DOI: 10.1016/S0161-6420(03)00463-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  125 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Effect of incision width on graft survival and endothelial cell loss after Descemet stripping automated endothelial keratoplasty.

Authors:  Marianne O Price; Maria Bidros; Mark Gorovoy; Francis W Price; Beth A Benetz; Harry J Menegay; Sara M Debanne; Jonathan H Lass
Journal:  Cornea       Date:  2010-05       Impact factor: 2.651

3.  Glaucoma in penetrating keratoplasty: risk factors, management and outcome.

Authors:  Klaudia K Huber; Anna-Karina B Maier; Matthias K J Klamann; Jessica Rottler; Sevil Özlügedik; Katja Rosenbaum; Johannes Gonnermann; Sibylle Winterhalter; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-30       Impact factor: 3.117

4.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

5.  Subconjunctival injection of in vitro transforming growth factor-β-induced regulatory T cells prolongs allogeneic corneal graft survival in mice.

Authors:  Qing Xu; Xiaobo Tan; Yingnan Zhang; Ying Jie; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 6.  Graft failure IV. Immunologic mechanisms of corneal transplant rejection.

Authors:  Eva-Marie Chong; M Reza Dana
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

7.  Overcoming the technical challenges of deep lamellar keratoplasty.

Authors:  M Yamada
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 8.  Indications, surgical procedures and outcomes of keratoplasty at a Tertiary University-based hospital: a review of 10 years' experience.

Authors:  Eman M Al-Sharif; Majed Alkharashi
Journal:  Int Ophthalmol       Date:  2021-02-24       Impact factor: 2.031

9.  Murine corneal transplantation: a model to study the most common form of solid organ transplantation.

Authors:  Xiao-Tang Yin; Deena A Tajfirouz; Patrick M Stuart
Journal:  J Vis Exp       Date:  2014-11-17       Impact factor: 1.355

10.  New surgical approaches to the management of keratoconus and post-LASIK ectasia.

Authors:  Bryan U Tan; Tracy L Purcell; Luis F Torres; David J Schanzlin
Journal:  Trans Am Ophthalmol Soc       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.